Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 181,244 | 163,926 | 169,467 | 160,341 | 171,955 |
| Cost of Goods | 47,692 | 39,750 | 48,207 | 49,020 | 61,916 |
| Gross Profit | 133,552 | 124,176 | 121,260 | 111,321 | 110,039 |
| Operating Expenses | 101,076 | 107,205 | 81,590 | 114,432 | 120,848 |
| Operating Income | 33,168 | 17,721 | 39,877 | -3,091 | -9,893 |
| Interest Expense | 3,388 | 3,464 | 3,865 | 9,589 | 11,041 |
| Other Income | 3,940 | 2,344 | 1,842 | -13,794 | 2,866 |
| Pre-tax Income | 33,720 | 16,601 | 37,854 | -26,474 | -18,068 |
| Income Tax | 8,850 | 5,743 | 12,091 | -6,938 | -7,966 |
| Net Income Continuous | 24,870 | 10,858 | 25,763 | -19,536 | -10,102 |
| Net Income | $24,870 | $10,858 | $25,763 | $-19,536 | $-10,102 |
| EPS Basic Total Ops | 0.55 | 0.23 | 0.56 | -0.43 | -0.22 |
| EPS Basic Continuous Ops | 0.54 | 0.23 | 0.56 | -0.43 | -0.22 |
| EPS Diluted Total Ops | 0.58 | 0.23 | 0.51 | -0.43 | -0.19 |
| EPS Diluted Continuous Ops | 0.53 | 0.21 | 0.49 | -0.43 | -0.17 |
| EBITDA(a) | $47,786 | $36,862 | $59,650 | $18,123 | $22,656 |